Gene Therapy: The Future of Healthspan

Dr. Esra Çavuşoğlu, PhD’s 71st Ayık Kafa podcast guest is Liz Parrish. Liz Parrish explores the transformative potential of gene therapy in extending human longevity and enhancing healthspan. Liz Parrish MBA, is the Founder and CEO of BioViva Sciences USA Inc. BioViva is committed to extending healthy lifespans using gene therapy and works on combinatorial gene therapies with its proprietary CMV gene therapy deliveryplatform. Liz is a humanitarian, entrepreneur, author, and innovator. In addition, she is a proponent of the Best Choice Medicine plan (BCM), a more efficient and streamlined regulatory model around the use of genetic therapies.  She shares her personal journey, the scientific basis for gene therapy, and the economic implications of aging-related diseases. The podcast also takes a closer look at the fourdifferent gene therapies that Liz Parrish administered to herself: Klotho, Follistatin, PGC-1α, and Telomerase Reverse Transcriptase. The discussion covers the various gene therapies being developed, their safety, ethicalconsiderations, and the importance of early intervention. Liz emphasizes the need for public awareness and investment in longevity research to make these therapies accessible to all. #EsraÇavuşoğlu #AyıkKafa #ElevatingLifeEvolvingHealth #Longevilab #LizParrish #Longevity#genetherapy Liz Parrish:Website: https://bioviva-science.com/about-us Instagram: https://www.instagram.com/lizlparrish/  *Collaborations & Sponsors:  https://dotshub.com/  Special thanks to T.C. Istanbul Gedik University https://www.gedik.edu.tr/en/  00:00-03:28 Introduction to longevityand gene therapy03:28-07:42 The role of gene therapy in healthspan07:42-11:25 Understanding gene therapy and its applications11:25-15:29 Liz Parrish's journey and motivation15:29-19:22 The economic impact of aging and disease19:22-21:03 Choosing genes for therapy21:03-27:02 Outcomes of gene therapy trials27:02-32:30 Safety and ethical considerations in gene therapy32:30-32:43 Personal impact and future aspirations32:43-36:04 Innovative approaches to type 1 diabetes36:04-39:35 Advancements in gene therapy39:35-40:48 The cost of gene therapies40:48-47:53 Revolutionizing stem cell treatments47:53-49:36 The future of neurodegenerative disease treatments49:36-56:10 The state of aging research56:10-01:00:00 The importance of early intervention01:00:00-01:02:01 A call to action for gene therapy awareness. Wrap up.  *To subscribe to our channel 👉* https://www.youtube.com/@ayikkafa *Dr. Esra Çavuşoğlu, PhD* Instagram:https://www.instagram.com/esracavusoglu/  https://www.instagram.com/longevilab Web:https://www.longevilab.com/hakkimizda#esra-cavusoglu  *To Reach Us 👉* [email protected]  *About Ayık Kafa* Dr.Esra Çavuşoğlu, PhD, took her studies, starting from her personal treatment experiences and continuing with her clinical psychology education, to the nextlevel by completing her PhD focused on Addiction. Dr. Esra in Ayık Kafa podcast discusses the world’s latest technologies, protocols, products and research in the fields of Biohacking and Longevity, while sharing first-hand information and experiences about the Disease of Addiction, as well as her latest academicstudies. *About Dr. Esra Çavuşoğlu, PhD* Longevilab's founder, Dr. Esra, is a UnitedStates and internationally trained clinical psychologist and a certifiedaddiction therapist in New York. She served as International DevelopmentAdvisor on the Yale University Faculty of Medicine Clinical Advisory Board. Sheis the founder and supervisor of Gaziantep Oya Bahadır Yüksel RehabilitationCenter, Dr. Esra is the designer and implementer of the Turkey RehabilitationModel. Dr. Esra founded the Contemporary Addiction Studies Association(ÇABAÇAD) in order to combat Turkey's growing addiction problem.